An editorial summarizing eight contributions describes cancer drug resistance as an adaptive process involving genetic, ...
The FDA rebuked Baxter in a lengthy warning letter that outlined a series of production violations that led to a trio of ...
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the European Commission (EC) has approved KEYTRUDA® (pembrolizumab), Merck’s anti-PD-1 therapy, in combination ...
The above raises concerns that unless the model… and any wider product safety implications are further examined, ...
For decades, the standard of care for patients with resected stage II and III colon cancer has centred on surgery with consideration of postoperative adjuvant systemic therapy to reduce risk of ...
Have you ever sighed after looking at a report from the field following a defect or a near-miss incident?The cause column ...
Experimental, randomised and clinical evidence indicates that mesh geometry and defect matching may be more important than ...
BERKELEY HEIGHTS, N.J., Oct. 19, 2026 (GLOBE NEWSWIRE) -- (Nasdaq: TNXP) (“Tonix” or the “Company”), a fully integrated, ...
IntroductionWhen a workplace accident occurs, have you ever taken measures like these as a way to prevent recurrence?"From ...
A 49-year-old cancer survivor who experienced severe facial deformity following cancer treatment has undergone complex jaw ...
National Air Traffic Services has traced the September 8 flight-plan processing failure linked to more than 2,000 ...
Mayo Clinic says tt three years, 86.3% of patients who received immunotherapy plus chemotherapy were alive and free of ...